A comprehensive view of Journal of the American Medical Association JAMA. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA to discuss Eli Lilly's Alzheimer's treatment, donanemab, at advisory committee meeting; results from phase 3 trial have been published in the Journal of the American Medical Assn.

Obesity patients regain weight after quitting Eli Lilly's drug Zepbound, suggests a study published in the Journal of the American Medical Assn., study finds patients lost an average of 20.9% of body weight while on drug, regained 14% after stopping drug

Peer-reviewed study finds Pfizer's danuglipron oral weight loss drug proves as effective as Novo Nordisk's Ozempic injection in clinical trial; Pfizer drug offers a potentially more convenient treatment option: JAMA Network

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count